HAVCR2 and leukemia: In one study, researchers created a phage library from which anti‐human TIM antibodies were isolated and evaluated the killing ability of second‐generation TIM3 CAR‐T cells against leukaemia cell lines and primary AML cells in vitro and found that they had good anti‐leukaemia activity.83